NARA Discovery
Article Details
← Back to Search Results
Journal Article

Cantharellus guyanensis (Basidiomycota, Hydnaceae): A Gourmet Mushroom in the Brazilian Cerrado

Robson Bernardo Silveira-Silva; Felipe Wartchow; Lucas Leonardo-Silva; Fábio Neves Vieira; Solange Xavier-Santos
Current Microbiology · Vol. 83, Issue 6 · 2026

Abstract

Cantharellus is an important genus of edible fungi with a worldwide distribution, whose species are recognized for their exceptional taste, beauty, and unique texture. Species of Cantharellus are terrestrial ectomycorrhizal fungi valued for their nutritional and medicinal properties, with demonstrated therapeutic potential due to their anti-inflammatory, antimicrobial, and antigenotoxic activities. Cantharellus guyanensis , originally described in 1854 from French Guiana, grows on soil and is currently known from restricted areas in South America, including the Amazon and Atlantic forests in Brazil. Appreciated in gourmet cuisine, C. guyanensis is reported here for the first time in the Cerrado biome. The species was confirmed through morphological and phylogenetic analysis (ITS, LSU and TEF1-α genetic markers), and the voucher is deposited in the fungaria of the Universidade Estadual de Goiás (HUEG-Fungi) and Universidade Federal da Paraíba (JPB). Its nutritional potential determined by bromatological analysis revealed good storage stability, maintaining its high concentration of general digestible nutrients and low lipid contents. This record expands knowledge about the distribution of the genus among Brazilian biomes and reveals an excellent alternative food resource for the Cerrado.

Bibliographic Information

JournalCurrent Microbiology
PublisherSpringer
Publication Date2026-06-01
Publication Year2026
Volume83
Issue6
Document TypeJournal Article
Print ISSN0343-8651
eISSN1432-0991
DOI10.1007/s00284-026-04899-x

Access Information

NARA Access Coverage1978-01-01~Current
Journal Homepagehttps://www.springer.com/journal/284
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.